• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Questions Email, March 5, 2009 - Anascorp

From: Cordaro, Debbie [mailto:Debbie.Cordaro@fda.hhs.gov]
Sent: Thursday, March 05, 2009 6:32 PM
To: ----(b)(4)----
Subject: Question about STN 125335
Importance: High
 
-(b)(4)-,
The reviewers need you to help them find in this submission your process
validation for bulk drug substance manufacture, and clarify which lots are your
process validation (conformance) lots. 
Please send this information on 3/6/09.
 

Thanks,
 

Debbie